Shermaine Tilley
InvestorManaging Partner at CTI Life Sciences Fund L.P. · Board director at Zymeworks
Toronto, Ontario, Canada
About
A founding member of CTI Life Sciences Fund since 2006, Shermaine has been involved in every fund, leading investments in companies such as Medicago, Zymeworks, Vaxcyte, IMV and Phenomic AI. Prior to CTI LSF she was Senior VP at DRI Capital and held faculty positions at NYU School of Medicine and PHRI; she holds a Ph.D. in biochemistry from Johns Hopkins and an MBA from the University of Toronto.
Contact· self-published, not guessed
Board director at Zymeworks
Intro paths
→
In turn, Shermaine can intro founders to Zymeworks's investors below.
Zymeworks's investors · 5
Co-founders at Zymeworks
AT
ALI TEHRANIExecutive Officer, Director
Experience
- CTI Life Sciences FundsManaging Partnercurrent2006 — presentGreater Toronto Area, Canada
- AbilityPharmaCorporate Directorcurrent2024 — presentBarcelona, Catalonia, Spain
- Phenomic AICorporate Directorcurrent2020 — presentToronto, Ontario, Canada
- BIOTECanada Gold Leaf AwardsCommittee Membercurrent2023 — presentOttawa, Ontario, Canada
- PHEMICorporate Director2015 — 2024Vancouver, British Columbia, Canada
- MaRS InnovationBoard Member and Chair, Investment Committee2019 — 2023Greater Toronto Area, Canada
- Immunovaccine Inc.Corporate Director, Public Company2016 — 2023Halifax, Nova Scotia, Canada
- BIOTECanadaBoard Member2015 — 2022Ottawa, Ontario, Canada
- CellAegis Devices Inc.Corporate Director2017 — 2019Greater Toronto Area, Canada
- Xagenic Inc.Corporate Director2012 — 2017Toronto, Ontario, Canada
- ZymeworksCorporate Director2009 — 2017Vancouver, British Columbia, Canada and Seattle, Washington, U.S.
- Enobia PharmaBoard Observer2007 — 2012
- Drug Royalty CorporationSenior VP2000 — 2005Toronto, Ontario, Canada
Skills & more
Corporate StrategyCorporate GovernanceBiotechnology20Corporate Development7Lifesciences11Venture Capital22Due Diligence12Commercialization12Royalty financingDrug Development2Pharmaceutical Industry2Biopharmaceuticals4
+7 more
Drug DiscoveryVenture FinancingBiochemistryClinical DevelopmentPatentsImmunologyLife SciencesFrom Shermaine's professional profile.
Deals · 1
ZymeworksBoard seat
via CTI Life Sciences Fund L.P. · filed Jan 2015 · $8.6M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at CTI Life Sciences Fund L.P.
Dana Matzen
Partner at CTI Life Sciences Fund L.P.
Ken Pastor
Managing Partner at CTI Life Sciences Fund L.P.
Laurence Rulleau
Managing Partner at CTI Life Sciences Fund L.P.
Paul Cassar
Associate at CTI Life Sciences Fund L.P.
Radhika Gupta
Principal at CTI Life Sciences Fund L.P.
Shermaine Tiley
Managing Partner at CTI Life Sciences Fund L.P.
Xin Hang
Principal at CTI Life Sciences Fund L.P.
Youssef Bennani
Managing Partner at CTI Life Sciences Fund L.P.
Frequently asked questions
- Who is Shermaine Tilley?
- A founding member of CTI Life Sciences Fund since 2006, Shermaine has been involved in every fund, leading investments in companies such as Medicago, Zymeworks, Vaxcyte, IMV and Phenomic AI. Prior to CTI LSF she was Senior VP at DRI Capital and held faculty positions at NYU School of Medicine and PHRI; she holds a Ph.D. in biochemistry from Johns Hopkins and an MBA from the University of Toronto.
- Where does Shermaine Tilley work?
- Shermaine Tilley is Managing Partner at CTI Life Sciences Fund L.P. and Board director at Zymeworks.
- What boards does Shermaine Tilley sit on?
- Shermaine Tilley holds tracked board seats at Zymeworks.
- Where did Shermaine Tilley go to school?
- Shermaine Tilley studied at University of Toronto - Rotman School of Management (MBA, Finance); The Johns Hopkins University School of Medicine (Ph.D., Biochemistry & Molecular Biology); Oklahoma City University (B.A., Chemistry).
Same school
Also attended University of Toronto - Rotman School of Management95
Clayton MacDougaldInvestment Director - Water at Emerald Technology Ventures AgLeah MorrisExecutive Director, Encode: AI for Science at Pillar VCKaty YamGeneral Manager at Inovia CapitalGreg AllenPartner at ChrysalixIvan YuenInvestor at AgeTech CapitalPeter Seufer-WasserthalExecutives in Residence at GENERAL INCEPTION
+ 89 more
Also attended The Johns Hopkins University School of Medicine28
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersS.K. LeeExecutive Coach at Roble VenturesKayarash KarimianSenior Associate at Cure VenturesSamantha GuinnAnalyst at Novartis Venture Fund
.png)
+ 22 more
